Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023:1416:5-20.
doi: 10.1007/978-3-031-29750-2_2.

Clinical Presentation and Prognosis

Christopher P Millward  1   2 , Sumirat Keshwara  1   2 , Abdurrahman I Islim  1   2 , Rasheed Zakaria  1   2 , Michael D Jenkinson  3   4
Affiliations

Clinical Presentation and Prognosis

Christopher P Millward et al. Adv Exp Med Biol. 2023.

Abstract

Over the past three decades, the care for patients with meningioma has steadily improved as a result of a better understanding of the natural history, molecular biology, and classification of these tumors. Surgical frameworks for management have been established and validated with more options for adjuvant and salvage treatment available for patients with residual or recurrent disease. Overall these advances have improved clinical outcomes and prognosis.Alongside the improved clinical management has come an increase in biological understanding of these tumors. The number of publications within the field of meningioma research continues to expand and biological studies identifying molecular factors at the cytogenic and genomic level offer exciting potential for more personalized management strategies. As survival and understanding have increased, treatment outcomes are moving from traditional metrics, which describe the morbidity and mortality to more patient-centered measures. The subjective experiences of patients with meningioma are gaining interest among clinical researchers and it is recognized that even supposedly mild symptoms arising from meningioma can have a significant effect on a patient's quality of life.This chapter reviews the varied clinical presentations of meningioma, which in the modern era of widespread brain imaging must include a discussion of incidental meningioma. The second part examines prognosis and the clinical, pathological, and molecular factors that can be used to predict outcomes.

Keywords: Clinical trial; Incidental; Meningioma; Radiotherapy; Surgery.

PubMed Disclaimer

References

    1. Buerki, R.A., et al., An overview of meningiomas. Future oncology (London, England), 2018. 14(21): p. 2161–2177.
    1. Beaumont, A. and I.R. Whittle, The Pathogenesis of Tumour Associated Epilepsy. Acta Neurochirurgica, 2000. 142(1): p. 1–15.
    1. Baumgarten, P., et al., Focused review on seizures caused by meningiomas. Epilepsy & Behavior, 2018. 88: p. 146–151.
    1. Tanti, M.J., A.G. Marson, and M.D. Jenkinson, Epilepsy and adverse quality of life in surgically resected meningioma. Acta Neurologica Scandinavica, 2017. 136(3): p. 246–253.
    1. Lieu, A.-S. and S.-L. Howng, Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors. Epilepsy Research, 1999. 38(1): p. 45–52.

Substances

LinkOut - more resources